Literature DB >> 16437644

Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis.

Hong-Cui Cao1, Xiao-Ming Chen, Wei Xu.   

Abstract

AIM: To detect the platelet-activating factor (PAF) and the plasma or serum levels of tumor necrosis factor-alpha (TNF-alpha) malondialdehyde (MDA), endotoxin (ET) and to discuss their significance in various types of viral hepatitis.
METHODS: PAF, TNF-alpha, MDA, and ET levels in 60 controls, 16 cases of acute viral hepatitis, 71 cases of chronic viral hepatitis, 19 cases of severe viral hepatitis were detected by reverse phase high-performance liquid chromatography (rHPLC), bio-assay, ELISA, thiobarbituric acid (TBA), and limulus lysate test (LLT), respectively.
RESULTS: The rHPLC was more sensitive and specific than bio-assay (r = 0.912, P<0.01). The plasma levels of PAF, TNF-alpha, MDA, and ET in patients with viral hepatitis were higher than those in controls (P<0.01).
CONCLUSION: rHPLC is more reliable and accurate for the detection of PAF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437644      PMCID: PMC4725131          DOI: 10.3748/wjg.v11.i46.7364

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Studies of the nature of the binding by albumin of platelet-activating factor released from cells.

Authors:  A J Ammit; C O'Neill
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion.

Authors:  Danielle G Souza; Mauro M Teixeira
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

3.  Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide.

Authors:  Qi Cao; Ki M Mak; Charles S Lieber
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07       Impact factor: 4.052

4.  Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration.

Authors:  A D Grypioti; S E Theocharis; G K Papadimas; C A Demopoulos; Z Papadopoulou-Daifoti; A C Basayiannis; M G Mykoniatis
Journal:  Arch Toxicol       Date:  2005-07-02       Impact factor: 5.153

5.  Expression of CD163 in the liver of patients with viral hepatitis.

Authors:  Atsushi Hiraoka; Norio Horiike; Sk Md Fazle Akbar; Kojiro Michitaka; Takami Matsuyama; Morikazu Onji
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

6.  A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry.

Authors:  Yoshihiro Kita; Toshie Takahashi; Naonori Uozumi; Takao Shimizu
Journal:  Anal Biochem       Date:  2005-07-01       Impact factor: 3.365

7.  Effects of nitric oxide on platelet-activating factor- and alpha-adrenergic-stimulated vasoconstriction and glycogenolysis in the perfused rat liver.

Authors:  J A Moy; J N Bates; R A Fisher
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

8.  An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry.

Authors:  John S Owen; Robert L Wykle; Michael P Samuel; Michael J Thomas
Journal:  J Lipid Res       Date:  2004-11-01       Impact factor: 5.922

9.  Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles.

Authors:  Junji Watanabe; Gopal K Marathe; Paul O Neilsen; Andrew S Weyrich; Kathleen A Harrison; Robert C Murphy; Guy A Zimmerman; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

10.  Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.

Authors:  Gou Murohisa; Yoshimasa Kobayashi; Tsunehisa Kawasaki; Satoshi Nakamura; Hirotoshi Nakamura
Journal:  Liver       Date:  2002-10
View more
  1 in total

1.  Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriers.

Authors:  Meredith A Jackson; Shrusti S Patel; Fang Yu; Matthew A Cottam; Evan B Glass; Ella N Hoogenboezem; R Brock Fletcher; Bryan R Dollinger; Prarthana Patil; Danielle D Liu; Isom B Kelly; Sean K Bedingfield; Allyson R King; Rachel E Miles; Alyssa M Hasty; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.